Jeffrey V. Matous
Oncology
1721 E 19th Ave Ste 100
Denver, CO 80218
Denver, CO 80218
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab.
Journal: The New England journal of medicine
Published: December 08, 2025
Dexamethasone prophylaxis for excessive lymphocyte expansion after cilta-cel in multiple myeloma.
Journal: Blood advances
Published: October 22, 2025
Dexamethasone prophylaxis for excessive lymphocyte expansion after cilta-cel in multiple myeloma.
Journal: Blood advances
Published: October 22, 2025
Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics.
Journal: Targeted oncology
Published: September 26, 2025
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.
Journal: Nature communications
Published: August 01, 2025
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia.
Journal: Seminars in hematology
Published: June 27, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy.
Journal: Seminars in hematology
Published: April 19, 2025
Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia.
Journal: Seminars in hematology
Published: April 10, 2025
Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.
Journal: Seminars in hematology
Published: April 06, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease.
Journal: Seminars in hematology
Published: April 04, 2025
Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors.
Journal: Seminars in hematology
Published: April 02, 2025
Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia.
Journal: Seminars in hematology
Published: April 02, 2025
Last Updated: 09/26/2026